Status: current, Defined. Date: 31-Aug 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4607841000168116 | elasomeran (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4607851000168119 | elasomeran | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4607961000168112 | mRNA-1273 encoding SARS-CoV-2 spike protein | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4607971000168118 | COVID-19 mRNA-1273 vaccine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| elasomeran | Is a | medicinal product | true | Inferred relationship | Some | ||
| elasomeran | has intended active ingredient | elasomeran | true | Inferred relationship | Some | 1913689719 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| elasomeran 200 microgram/mL injection, 5 mL vial | Is a | True | elasomeran | Inferred relationship | Some | |
| elasomeran + imelasomeran | Is a | True | elasomeran | Inferred relationship | Some | |
| elasomeran 100 microgram/mL injection, 2.5 mL vial | Is a | True | elasomeran | Inferred relationship | Some | |
| elasomeran + davesomeran | Is a | True | elasomeran | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR